Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
7 Mar 22
Current reports
8-K
Entry into a Material Definitive Agreement
22 Apr 24
8-K
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
28 Mar 24
8-K
Danimer Scientific Announces $15 Million Registered Direct Offering
25 Mar 24
8-K
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
20 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Jan 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K
Danimer Scientific Announces Third Quarter 2023 Results
14 Nov 23
8-K
Danimer Scientific Announces Second Quarter 2023 Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
5 Jun 23
8-K
Danimer Scientific Announces First Quarter 2023 Results
10 May 23
Registration and prospectus
424B3
Prospectus supplement
22 Apr 24
424B3
Prospectus supplement
1 Apr 24
424B5
Prospectus supplement for primary offering
22 Mar 24
424B5
Prospectus supplement for primary offering
21 Mar 24
424B3
Prospectus supplement
30 Jan 24
424B3
Prospectus supplement
18 Jan 24
424B3
Prospectus supplement
15 Nov 23
424B3
Prospectus supplement
8 Aug 23
424B3
Prospectus supplement
5 Jun 23
424B3
Prospectus supplement
10 May 23
Other
EFFECT
Notice of effectiveness
8 Sep 22
CORRESP
Correspondence with SEC
2 Sep 22
UPLOAD
Letter from SEC
1 Sep 22
UPLOAD
Letter from SEC
11 Aug 22
CORRESP
Correspondence with SEC
1 Aug 22
UPLOAD
Letter from SEC
18 Jul 22
EFFECT
Notice of effectiveness
17 Feb 21
CORRESP
Correspondence with SEC
16 Feb 21
UPLOAD
Letter from SEC
4 Feb 21
EFFECT
Notice of effectiveness
17 Dec 20
Ownership